Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Healthcare Reform Returns To Political Agenda Heading Into 2002 Elections

Executive Summary

The lessons of the 1998 and 2000 elections may encourage action on a Medicare prescription drug benefit in 2002, Republican pollster Bill McInturff said during the National Health Policy Conference in Washington, D.C., Jan. 16

You may also be interested in...



House Medicare Rx Bill Would Attract 90% Of Beneficiaries, Staffer Says

House Republicans are confident that their Medicare prescription drug benefit proposal will attract at least 90% of the eligible population, Ways & Means/Health Subcommittee Staff Director John McManus said

House Medicare Rx Bill Would Attract 90% Of Beneficiaries, Staffer Says

House Republicans are confident that their Medicare prescription drug benefit proposal will attract at least 90% of the eligible population, Ways & Means/Health Subcommittee Staff Director John McManus said

AARP Medicare Rx “Reserve” Proposal Seeks To Bypass Cost Debate

AARP is suggesting tapping the Medicare trust fund surplus as a way to finesse the cost-estimate barrier to a comprehensive prescription drug benefit

Related Content

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel